Recent press releases

• May

  02

  2013

  CLC bio moves Danish headquarters to landmark building in Aarhus

  On May 1st, CLC bio moved their Danish headquarters to
  Prismet - a local landmark highrise office building in Aarhus.

• Apr

  09

  2013

  IBM and CLC bio deliver combined turnkey genomics sequencing analytics solution

  IBM and CLC bio announces a combined turnkey genomics sequencing analytics solution. It's a scalable end-to-end solution that integrates a computing...

• Mar

  12

  2013

  CLC bio releases module for microbial genome finishing

  Today CLC bio released CLC Microbial Genome Finishing Module, an add-on module to CLC Genomics Workbench, which has been developed to help finish the...

• Feb

  12

  2013

  CLC bio continues success with a 30 percent growth in software sales and over 500 new organizations as customers in 2012

  In many ways, 2012 featured significant milestones for us as a company. We now have more than 100 employees around the world...

• Jan

  08

  2013

  J. Craig Venter Institute extends CLC bio site license through 2017

  Aarhus, Denmark — January 8, 2013 — Today CLC bio, the global leader in commercial sequence analysis software, announced that the J. Craig...

• Dec

  12

  2012

  CLC bio part of $7.8M EU STATegra grant to develop integral analysis platform for epigenetics

  Aarhus, Denmark — December 12, 2012 — Today CLC bio announced the participation in the European FP7 project, STATegra, and receives 1.3 million...

• Nov

  07

  2012

  CLC bio and BioQL release medical genomics plugin for genotype–phenotype associations

  Aarhus, Denmark — November 7, 2012 — Today, CLC bio and the independent software vendor, BioQL, announced the release of the MedQL Variant...

• Oct

  10

  2012

  CLC bio’s read mapping algorithm beats popular open source alternatives in benchmarks

  Vienna, Austria — October 10, 2012 — Today at the Bio-IT World conference in Vienna, CLC bio officially released the white paper on its new...

• Sep

  03

  2012

  CLC bio acquires the drug discovery-software company Molegro

  Today, CLC bio announced the acquisition of Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of...

• Aug

  30

  2012

  CLC bio part of $ 10M EU PATHSEEK project

  CLC bio, the world's leading bioinformatics software developer, has been awarded a share of a EU-funded clinical research grant, PATHSEEK, worth $ 2...